These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 256523)

  • 1. Piperacillin and carbenicillin; a collaborative in vitro comparison against 10,838 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gerlach EH; Gavan TL
    Cleve Clin Q; 1979; 46(2):49-55. PubMed ID: 256523
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.
    Jones RN; Packer RR; Barry AL; Badal RE; Thornsberry C; Baker C
    J Antibiot (Tokyo); 1979 Jan; 32(1):29-35. PubMed ID: 761991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of the carbenicillin-gentamicin combination against gram-negative bacilli.
    Klastersky J; Swings G; Daneau D
    Am J Med Sci; 1970 Dec; 260(6):373-80. PubMed ID: 4997207
    [No Abstract]   [Full Text] [Related]  

  • 7. Interpretation of diffusion susceptibility data obtained with 50-mu g carbenicillin discs against gram-negative organisms.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Nov; 22(5):862-4. PubMed ID: 5210841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro examination of some new penicillin derivatives with activity against Pseudomonas aeruginosa: azlocillin, mezlocillin and piperacillin compared with carbenicillin].
    Høiby N; Bremmelgaard A; Schouenborg P
    Ugeskr Laeger; 1979 Oct; 141(41):2815-8. PubMed ID: 120049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance of enterococci to penicillin, cephalosporins and classical broad spectrum antibiotics].
    Schaal KP; Rütten D
    Med Welt; 1973 Mar; 24(11):402-5. PubMed ID: 4488109
    [No Abstract]   [Full Text] [Related]  

  • 10. Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin.
    Finland M; McGowan JE; Garner C; Wilcox C
    J Infect Dis; 1974 Jun; 129(0):suppl:S132-8. PubMed ID: 4210005
    [No Abstract]   [Full Text] [Related]  

  • 11. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC; Gavan TL; Gerlach EH; Jones RN; Barry AL; Thornsberry C
    Am J Med Sci; 1977; 274(3):255-63. PubMed ID: 610415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.
    Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH; Jones RN
    J Antibiot (Tokyo); 1977 Dec; 30(12):1098-106. PubMed ID: 599083
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative "in vitro" activity of pirbenicillin and carbenicillin against clinical and environmental "Pseudomonas aeruginosa" isolates from hospitals.
    Castellani Pastoris M; Mondello F; Gennaro ML; Greco D
    Ann Sclavo; 1980; 22(6):931-9. PubMed ID: 6794465
    [No Abstract]   [Full Text] [Related]  

  • 14. Susceptibility of gram-negative aerobic bacilli resistant to carbenicillin in a general hospital to piperacillin and ticarcillin.
    McGowan JE; Terry PM
    Antimicrob Agents Chemother; 1979 Jan; 15(1):137-39. PubMed ID: 426501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative activity of furbenicillin and carbenicillin-like compounds.
    Li JT; Williams JD
    J Antimicrob Chemother; 1982 Mar; 9(3):171-81. PubMed ID: 6978880
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative activity of new semisynthetic penicillins and their combinations with gentamycin against gram-negative bacteria].
    Treskina OS; Slepchenko LM; Nasonov VN; Dutova EN
    Antibiot Med Biotekhnol; 1987 Nov; 32(11):855-9. PubMed ID: 3439791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies of BL-P1462, a new semisynthetic penicillin with anti-pseudomonas activity.
    Barza M; Berman H; Michaeli D; Molavi A; Weinstein L
    Antimicrob Agents Chemother (Bethesda); 1970; 10():341-5. PubMed ID: 5521354
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of carbenicillin and ticarcillin against Pseudomonas aeruginosa compared by paired in vitro tests.
    Mai K; Bülow B
    Infection; 1974; 2(1):12-4. PubMed ID: 4208532
    [No Abstract]   [Full Text] [Related]  

  • 20. Mezlocillin: a new acyl ureidopenicillin. Antimicrobial activity and combination effects with four aminoglycoside antibiotics.
    Schassan HH; Koperski K; Scherf H
    Chemotherapy; 1978; 24(3):134-42. PubMed ID: 95925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.